Skip to main content
SpringerLink
Log in
Book cover

Adjuvant Therapy for Breast Cancer pp 291–298Cite as

Young Patients with Breast Cancer

  • Chapter
  • First Online:

  • 1213 Accesses

Part of the book series: Cancer Treatment and Research ((CTAR,volume 151))

Among women diagnosed with early breast cancer, one in four will be premenopausal. In relation to breast cancer, the term “young” typically refers to patients aged less than 40 years. While breast cancer in young women is not common, breast cancer remains the leading cause of cancer deaths among young women. Only about 1 in 40 women diagnosed with breast cancer will be very young (defined here as <35 years).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Adami HO, Malker B, Holmberg L, et al. The relation between survival and age at diagnosis in breast cancer. NEJM. 1986;315:559–63.

    Article  PubMed  CAS  Google Scholar 

  2. De la Rochefordiere A, Asselain B, Campana F, et al. Age as a prognostic factor in premenopausal breast cancer. Lancet. 1993;341;1039–43.

    Article  PubMed  Google Scholar 

  3. Albain K, Allred C, Clark G. Breast cancer outcome and predictors of outcome: Are there age differentials? JNCI monographs. 1994;16:35–42.

    Google Scholar 

  4. Colleoni M, Rotmensz N, Peruzzotti G, et al. Role of endocrine responsiveness and adjuvant therapy in very young (below 35 years) with operable breast cancer and node negative disease. Ann Oncol. 2006;17:1497–503.

    Article  PubMed  CAS  Google Scholar 

  5. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting Highlights: International expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005;16:1569–83.

    Article  PubMed  CAS  Google Scholar 

  6. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;365:1687–717.

    Article  Google Scholar 

  7. Aebi S, Gelber S, Castiglione-Gertsch M, et al. Is chemotherapy alone adequate for young women with oestrogen-receptor positive breast cancer? Lancet. 2000;355:1869–74.

    Article  PubMed  CAS  Google Scholar 

  8. Goldhirsch A, Gelber RD, Yothers G, et al. Adjuvant therapy for very young women with breast cancer: Need for tailored treatments. JNCI Monographs. 2001;30:44–51.

    Article  Google Scholar 

  9. Pagani O, O’Neill A, Castiglione M, et al. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: Results of the International Breast cancer Study Group (IBCSG) Trial VI. Eur J Cancer. 1998;34:632–40.

    Article  PubMed  CAS  Google Scholar 

  10. Goldhirsch A, Gelber RD, Castiglione M. The magnitude of endocrine effect of adjuvant chemotherapy for premenopausal breast cancer patients. Ann Oncol. 1990;1:183–8.

    PubMed  CAS  Google Scholar 

  11. Tancini G, Valagussa P, Bajetta E, et al. Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancer. Cancer Clin Trials. 1979;2:285–92.

    PubMed  CAS  Google Scholar 

  12. Cobleigh M et al. Proc Am Soc Clin Oncol. 1995;14:A158.

    Google Scholar 

  13. Goodwin PJ, Ennis M, Pritchard KI, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17:2365–70.

    PubMed  CAS  Google Scholar 

  14. Davidson N, O’Neill AM, Vukov AM, et al. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: Results form INT 0101 (E5188). J Clin Oncol. 2005;23:5973–82.

    Article  PubMed  CAS  Google Scholar 

  15. International Breast Cancer Study Group. Adjuvant Chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trial. JNCI. 2003;95:1833–46.

    Google Scholar 

  16. Love RR, Nguyen BD, Nguyen VD, et al. Young age as an adverse prognostic factor in premenopausal women with operable breast cancer. Clin Breast Cancer. 2002;2:294–8.

    Article  PubMed  Google Scholar 

  17. Bartelink H, Horiot JC, Poortmans P, et al. Impact of radiation dose on local control, fibrosis and survival after breast conserving treatment:10 year results of the EORTC Trial 22881-10882. Breast Cancer Res and Treat. 2006;100(suppl 1, S8).

    Google Scholar 

  18. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiation and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of randomised trials. Lancet. 2005;366:2087–106.

    Google Scholar 

  19. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. J Clin Oncol. 2006;24:2917–31.

    Article  PubMed  Google Scholar 

  20. Guinee VF, Olsson H, Moller T, et al. Effect of pregnancy on prognosis for young women with breast cancer. Lancet. 1994;343:1587–1589.

    Article  PubMed  CAS  Google Scholar 

  21. Phillips KA, Milne RL, Friedlander ML, et al. Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol. 2004;22:699–705.

    Article  PubMed  Google Scholar 

  22. Dite GS, Jenkins MA, Hocking JS, et al. Familial risks, early onset breast cancer, and BRCA1 and BRCA2 germline mutations. JNCI. 2003;95:448–57.

    PubMed  CAS  Google Scholar 

  23. Ganz PA, Greendale GA, Petersen L, et al. Breast cancer in younger women: Reproductive and late health effects of treatment. J Clin Oncol. 2003;21:4184–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia

    P. A. Francis

Authors
  1. P. A. Francis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Inselspital, Univ. Bern, Bern, 3010, Switzerland

    Monica Castiglione

  2. Inst. Jules Bordet, Universite Libre Bruxelles, Bd. de Waterloo 125, Bruxelles, 1000, Belgium

    Martine J. Piccart

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Francis, P.A. (2009). Young Patients with Breast Cancer. In: Castiglione, M., Piccart, M. (eds) Adjuvant Therapy for Breast Cancer. Cancer Treatment and Research, vol 151. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75115-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-75115-3_18

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-75114-6

  • Online ISBN: 978-0-387-75115-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation